Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Ilenia Pellarin, Alessandra Dall’Acqua, Andrea Favero, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Discovery and significance of protein-protein interactions in health and disease
Jack Greenblatt, Bruce Alberts, Nevan J. Krogan
Cell (2024) Vol. 187, Iss. 23, pp. 6501-6517
Open Access | Times Cited: 9
Mechanisms and regulation of substrate degradation by the 26S proteasome
Connor Arkinson, Ken C. Dong, Christine L. Gee, et al.
Nature Reviews Molecular Cell Biology (2024)
Closed Access | Times Cited: 8
CUL4-Based Ubiquitin Ligases in Chromatin Regulation: An Evolutionary Perspective
Makiko Nakagawa, Tadashi Nakagawa
Cells (2025) Vol. 14, Iss. 2, pp. 63-63
Open Access | Times Cited: 1
Rational Design, Synthesis, and Biological Evaluation of Novel c-Met Degraders for Lung Cancer Therapy
Xingyang Qiu, Qingquan Zheng, Dongdong Luo, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Emerging Trends in DNA Nanotechnology-Enabled Cell Surface Engineering
Fan Xiao, Xuechu Shen, Wenqi Tang, et al.
JACS Au (2025) Vol. 5, Iss. 2, pp. 550-570
Open Access | Times Cited: 1
Reprograming of the ubiquitin ligase Ubr1 by intrinsically disordered Roq1 through cooperating multifunctional motifs
Niklas Peters, Sibylle Kanngießer, Oliver Pajonk, et al.
The EMBO Journal (2025)
Open Access | Times Cited: 1
Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis
Peng He, Chengming Wen, Xinyu Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Thirty years of NRF2: advances and therapeutic challenges
Donna D. Zhang
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
The value of protein allostery in rational anticancer drug design: an update
Ruth Nussinov, Hyunbum Jang
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1071-1085
Open Access | Times Cited: 7
PROTAC-DB 3.0: an updated database of PROTACs with extended pharmacokinetic parameters
Jingxuan Ge, Shimeng Li, Gaoqi Weng, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1510-D1515
Open Access | Times Cited: 7
Zinc finger proteins: guardians of genome stability
Zeeba Kamaliyan, Thomas L. Clarke
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Development of PROTACs using computational approaches
Jingxuan Ge, Chang-Yu Hsieh, Meijing Fang, et al.
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 6
LAPTM5 Confers the Resistance to Venetoclax via Promoting the Autophagosome‐Lysosome Fusion in Multiple Myeloma
Yuxiang Li, Jing Bai, Dan Liu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access
DNA Tetrahedron-Driven Multivalent Proteolysis-Targeting Chimeras: Enhancing Protein Degradation Efficiency and Tumor Targeting
Shiqing Li, Tao Zeng, Zhixing Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
Multifaceted roles of UFMylation in health and disease
R. Wang, Li Lin, Jun Zhou, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Differential Protein Degradation with a Super-Degron Tag and Thalidomide Analogs: EGFP is Degraded in Wild-Type Mouse Cell, While PD-1 Requires CRBN Humanization, Providing New Insights into T Cell Regulation
Chie Naruse, Osamu Ishibashi, Masatoshi Ohgushi, et al.
(2025)
Closed Access
Cullin-RING ligase BioE3 reveals molecular-glue-induced neosubstrates and rewiring of the endogenous Cereblon ubiquitome
Laura Merino‐Cacho, Orhi Barroso‐Gomila, Mónica Pozo-Rodríguez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection
Jinying Shen, Jing Li, Quan Shen, et al.
Nature Microbiology (2025)
Closed Access
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
Yanqing Zhang, Wenjing Liu, Chao Tong, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery of the First Potent ROR1 Degrader for the Treatment of Non-Small Cell Lung Cancer
Jinlin Li, Lin Li, Hou Cai-yun, et al.
European Journal of Medicinal Chemistry (2025), pp. 117325-117325
Closed Access
Genetically-encoded targeted protein degradation technology to remove endogenous condensation-prone proteins and improve crop performance
Ming Luo, Sitao Zhu, Hua Dang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Identification of actionable targeted protein degradation effector sites through Site-specific Ligand Incorporation-induced Proximity (SLIP)
Zhangping Xiao, Efthymios Spyridon Gavriil, Fangyuan Cao, et al.
(2025)
Open Access
Proteolysis-Targeting Chimera-Doxorubicin Conjugate Nanoassemblies for Dual Treatment of EGFR-TKI Sensitive and Resistant Non-Small Cell Lung Cancer
Junhui Ma, Ruixue Zhu, Meijing Li, et al.
Acta Biomaterialia (2025)
Closed Access
Page 1 - Next Page

Scroll to top